Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of Short-Term Response to Haloperidol Treatment With a Polymorphism in the Dopamine D<sub>2</sub> Receptor Gene

1 May 2001

Abstract excerpt

OBJECTIVE: Pharmacogenetic influences on therapeutic response to neuroleptic treatment are poorly understood. This study investigates the association of response to short-term haloperidol treatment with a Taq I polymorphism in the DRD2 gene. METHOD: Fifty-seven patients with acute psychosis were treated with haloperidol for up to 28 days. Improvement and response were measured by using the Positive and Negative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neurotransmitter Receptor Influence on Behavior
Share to Phosphodiesterase function and regulation
Share to Schizophrenia research and treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11329406
DOI: 10.1176/appi.ajp.158.5.802

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of Short-Term Response to Haloperidol Treatment With a Polymorphism in the Dopamine D<sub>2</sub> Receptor GenePMID 11329406Read ↗

D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis.Semantic proximity Read ↗

Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis.Semantic proximity Read ↗

Treatment Response and GWAS Risk Allele rs2514218 (C) of the Dopamine D2 Receptor Gene in Inpatients with Schizophrenia.Semantic proximity Read ↗

DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients.Semantic proximity Read ↗

Dopamine D2 receptor gene polymorphisms predict well the response to dopamine antagonists at therapeutic dosages in patients with schizophrenia.Semantic proximity Read ↗

Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting.Semantic proximity Read ↗

DRD2 genotypic and haplotype variation is associated with improvements in negative symptoms after 6 weeks' amisulpride treatment.Semantic proximity Read ↗

Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene.Semantic proximity Read ↗

Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatment.Semantic proximity Read ↗

T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability.Semantic proximity Read ↗

The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients.Semantic proximity Read ↗

Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.